A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients With Myelodysplastic Syndromes

NCT01571648 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene